Financhill
Back

PetMed Express 10K Form

Sell
28

PETS
PetMed Express

Last Price:
16.24
Seasonality Move:
15.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive PETS News And Ratings

See the #1 stock for the next 7 days that we like better than PETS

PETS Financial Statistics

Sales & Book Value

Annual Sales: $273.42M
Cash Flow: $11.98M
Price / Cash Flow: 14.35
Annual Sales: $6.34
Price / Book: 2.56

Profitability

EPS (TTM): 0.56910
Net Income (TTM): $11.4M
Gross Margin: $78.08M
Return on Equity: 8.2%
Return on Assets: 6.76%

PetMed Express Earnings Forecast

Key PetMed Express Financial Ratios

  • The Gross Profit Margin over the past 23 years for PETS is 28.56%.
  • The Selling, General & Administrative Expenses for PETS have been equal to 18.15% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of PETS is 7.72% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 16 years.

PetMed Express Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical Retailers
Sector: Healthcare
Current Symbol: PETS
CUSIP: 716382
Website: petmeds.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.31
Quick Ratio: 3.36

Price-to-Earnings

Trailing P/E Ratio: 15.61
Forward P/E Ratio: 14.36

PETS Technical Analysis vs Fundamental Analysis

Sell
28
PetMed Express (PETS) is a Sell

Is PetMed Express a Buy or a Sell?

  • PetMed Express stock is rated a Sell
    The current PetMed Express [PETS] share price is $16.23. The Score for PETS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.